164 related articles for article (PubMed ID: 8905740)
21. Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions.
Ben V; Blin O; Bruguerolle B
J Pharm Pharmacol; 1999 Dec; 51(12):1405-8. PubMed ID: 10678495
[TBL] [Abstract][Full Text] [Related]
22. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Moroz IA; Peciña S; Schallert T; Stewart J
Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
[TBL] [Abstract][Full Text] [Related]
23. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
[TBL] [Abstract][Full Text] [Related]
24. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728
[TBL] [Abstract][Full Text] [Related]
25. Left/right nigrostriatal asymmetry in susceptibility to neurotoxic dopamine depletion with 6-hydroxydopamine in rats.
Sullivan RM; Szechtman H
Neurosci Lett; 1994 Mar; 170(1):83-6. PubMed ID: 8041518
[TBL] [Abstract][Full Text] [Related]
26. Effect of different doses of estrogen on the nigrostriatal dopaminergic system in two 6-hydroxydopamine-induced lesion models of Parkinson's disease.
Cordellini MF; Piazzetta G; Pinto KC; Delattre AM; Matheussi F; Carolino RO; Szawka RE; Anselmo-Franci JA; Ferraz AC
Neurochem Res; 2011 Jun; 36(6):955-61. PubMed ID: 21347839
[TBL] [Abstract][Full Text] [Related]
27. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
[TBL] [Abstract][Full Text] [Related]
28. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
Robinson TE; Whishaw IQ
Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
[TBL] [Abstract][Full Text] [Related]
29. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
30. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
31. The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism.
Gonzalez-Aparicio R; Blanco E; Serrano A; Pavon FJ; Parsons LH; Maldonado R; Robledo P; Fernandez-Espejo E; de Fonseca FR
Int J Neuropsychopharmacol; 2014 Mar; 17(3):455-68. PubMed ID: 24169105
[TBL] [Abstract][Full Text] [Related]
32. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
33. Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.
Waldmeier PC; Feldtrauer JJ; Kam R; Stöcklin K
Eur J Pharmacol; 1979 Mar; 54(3):279-87. PubMed ID: 428427
[TBL] [Abstract][Full Text] [Related]
34. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
[TBL] [Abstract][Full Text] [Related]
35. Repeated exposure to the abused inhalant toluene alters levels of neurotransmitters and generates peroxynitrite in nigrostriatal and mesolimbic nuclei in rat.
Riegel AC; Ali SF; Torinese S; French ED
Ann N Y Acad Sci; 2004 Oct; 1025():543-51. PubMed ID: 15542760
[TBL] [Abstract][Full Text] [Related]
36. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
[TBL] [Abstract][Full Text] [Related]
37. Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives.
Grote C; Clement HW; Wesemann W; Bringmann G; Feineis D; Riederer P; Sontag KH
J Neural Transm Suppl; 1995; 46():275-81. PubMed ID: 8821064
[TBL] [Abstract][Full Text] [Related]
38. Progressive accumbens degeneration after neonatal striatal 6-hydroxydopamine in rats.
Teicher MH; Andersen SL; Campbell A; Gelbard HA; Baldessarini RJ
Neurosci Lett; 1998 May; 247(2-3):99-102. PubMed ID: 9655602
[TBL] [Abstract][Full Text] [Related]
39. Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine.
Nowak P; Kostrzewa RM; Kwieciński A; Bortel A; Labus Ł; Brus R
J Physiol Pharmacol; 2005 Jun; 56(2):325-33. PubMed ID: 15985712
[TBL] [Abstract][Full Text] [Related]
40. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system.
Javoy F; Sotelo C; Herbet A; Agid Y
Brain Res; 1976 Feb; 102(2):201-15. PubMed ID: 1247882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
